This invention relates to certain metabolites of N (1 methyl 5 (trifluoromethyl) 1H pyrazol 3 yl) 5 ((6 ((methylamino)methyl)pyrimidin 4 yl)oxy) 1H indole 1 carboxamide In particular the present invention relates to pharmaceutical compositions comprising these metabolites as well as processes for their preparation and their use in the treatment of diseases.